chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Runny nose; headache; I lost my smell; not feeling good; throat hurt; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 12Feb2021 (Batch/Lot number was not reported) as dose 2, single (at the age of 65-years-old) for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 22Jan2021 (Batch/Lot number EL9262, Expiration date: May2021) as dose 1, single for Covid-19 immunisation and had a light headache, face was swollen, throat was swollen little bit. On an unknown date, the patient had a light headache, runny nose and her throat hurt for one day. She stayed not feeling good for five days since 14Feb2021). She also lost her (sense of) smell to the day of the report and still had no sense of smell. The patient underwent lab tests and procedures which included COVID test: negative on 19Feb2021. The events not feeling good resolved on 19Feb2021, the event throat hurt resolved on an unspecified date in 2021, the event "I lost my smell" had not resolved, while the outcome of the rest of the events was unknown.   No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; Headache; fatigue; This is a spontaneous report from a contactable other hcp. A 26-years-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection,Batch/Lot Number: EL3246,Expiry date was not reported),via intramuscular route of administration, administered in Deltoid Left on 07Jan2021 12:40 as DOSE 1,SINGLE for COVID-19 immunisation (At the age vaccination-26yrs). Medical history included appendicitis from 14Feb2014 to 15Feb2014, asthma from Sep2009 and ongoing, irritable bowel syndrome, anxiety, contraception, hypersensitivity. Concomitant medication(s) included budesonide, formoterol fumarate (SYMBICORT) taken for asthma from 2018 and ongoing; hyoscyamine sulfate (LEVSIN) taken for inflammatory bowel disease from 2016 and ongoing; escitalopram oxalate (LEXAPRO) taken for anxiety from 2020 and ongoing; ethinylestradiol, norethisterone acetate (JUNE FE 1/20)taken for contraception from 2019 and ongoing; cetirizine hydrochloride (ZYRTEC ALLERGY) taken for hypersensitivity from 2008 and ongoing; fluticasone propionate (FLONASE ALLERGY RELIEF) taken for an unspecified indication from 2008 and ongoing. On 24Jan2021 01:00 the patient experienced fatigue, fever, headache. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 17Aug2020, sars-cov-2 test: negative on 28Aug2020, sars-cov-2 test: negative on 20Dec2020. Therapeutic measures were taken as a result for fever Tylenol and for headache Excedrin Migraine. And the clinical outcome of the event was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Body itches; This is a spontaneous report from a contactable consumer (the patient). A 78-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL6198), via an unspecified route of administration, administered in left arm on 23Feb2021 08:45 (at the age of 78-year-old) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9269), via an unspecified route of administration, administered in left arm on 02Feb2021 09:15 (at the age of 78-year-old) as dose 1, single for COVID-19 immunisation and had nausea (2days), headache, some body aches. Next day - 03Feb2021- Lightheadedness, body aches and around 13:00, both eyes severe itching. Used hot (wet) compress to eyes. Took allergy pills. On 23Feb2021, the patient experienced body itches. It was reported that body itches everyday (all over). Took allergy pill about one hour after vaccine. Take allergy pill every night. Therapeutic measures were taken as a result of body itches. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Incontinence, Myalgia, Nausea
Clinical narrative: projectile vomiting; Incontinence; Soreness and joint / muscle pain; Soreness and joint / muscle pain; nausea; Fever (peaking at 101.3 so far); This is a spontaneous report from a contactable consumer (patient) in response to Non-HCP letter sent in cross reference case which included that a 41-year-old female patient received second dose bnt162b2 (Formulation: Solution for injection; Lot Number: EN6198) via an unspecified route of administration on 17Feb2021 (at the age of 41 years old) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Patient historical vaccine includes first dose bnt162b2 (lot number: EL3247) on 27Jan2021 for Covid-19 immunisation and experienced soreness and joint/muscle pain, nausea, fever on 27Jan2021; elevated heart rate (peeking at 145) on 28Jan2021 and Incontinence on 29Jan2021. Concomitant medications included influenza vaccine (FLU VACCINE VII) taken for an unspecified indication from 25Jan2021 and ongoing; cannabis taken for an unspecified indication from May2019 and ongoing; dimenhydrinate taken for an unspecified indication at 50 mg from 28Jan2021 to 26Feb2021 and naproxen sodium at 220 mg taken for an unspecified indication from 28Jan2021 to 26Feb2021. The patient experienced soreness and joint / muscle pain, nausea, fever (peaking at 101.3 so far), projectile vomiting, incontinence on 17Feb2021. Patient did not have admission to hospital due to the event. Therapeutic measures were not taken as a result of the events. The outcome of the events soreness and joint/muscle pain, Fever (peaking at 101.3 so far), projectile vomiting was recovered on an unknown date in 2021; nausea, incontinence was not recovered. No follow-up attempts are needed. No lot/batch number requested. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting projectile
Clinical narrative: projectile vomiting; Incontinence; Soreness and joint / muscle pain; Soreness and joint / muscle pain; nausea; Fever (peaking at 101.3 so far); This is a spontaneous report from a contactable consumer (patient) in response to Non-HCP letter sent in cross reference case which included that a 41-year-old female patient received second dose bnt162b2 (Formulation: Solution for injection; Lot Number: EN6198) via an unspecified route of administration on 17Feb2021 (at the age of 41 years old) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Patient historical vaccine includes first dose bnt162b2 (lot number: EL3247) on 27Jan2021 for Covid-19 immunisation and experienced soreness and joint/muscle pain, nausea, fever on 27Jan2021; elevated heart rate (peeking at 145) on 28Jan2021 and Incontinence on 29Jan2021. Concomitant medications included influenza vaccine (FLU VACCINE VII) taken for an unspecified indication from 25Jan2021 and ongoing; cannabis taken for an unspecified indication from May2019 and ongoing; dimenhydrinate taken for an unspecified indication at 50 mg from 28Jan2021 to 26Feb2021 and naproxen sodium at 220 mg taken for an unspecified indication from 28Jan2021 to 26Feb2021. The patient experienced soreness and joint / muscle pain, nausea, fever (peaking at 101.3 so far), projectile vomiting, incontinence on 17Feb2021. Patient did not have admission to hospital due to the event. Therapeutic measures were not taken as a result of the events. The outcome of the events soreness and joint/muscle pain, Fever (peaking at 101.3 so far), projectile vomiting was recovered on an unknown date in 2021; nausea, incontinence was not recovered. No follow-up attempts are needed. No lot/batch number requested. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Salivary hypersecretion
Clinical narrative: Strong metallic taste in mouth at all times; Significantly increased salivation interfering with daily activities; This is a spontaneous report from a contactable Other HCP (patient). A 37-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Unknown lot number) via intramuscular route administered on left arm on 21Jan2021 9:00 AM ((age at vaccination: 37 years) as a dose 2, single for COVID-19 immunisation. The medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Unknown lot number) via intramuscular route administered on left arm on 07Jan2021 9:00 AM (age at vaccination: 37 years) as dose 1, single for Covid-19 immunisation. Patient had no covid prior vaccination. Patient did not test Covid post vaccination. On 21Jan2021, patient had strong metallic taste in mouth at all times. Significantly increased salivation interfering with daily activities. The patient did not receive any treatment for the events. The outcome of the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Faeces soft, Myalgia, Neck pain, Vaccination site pain
Clinical narrative: injection site was painful; shoulder muscle hurt; big artery y in back of my neck hurt; bowel movement was soft; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiration date: not reported), via an unspecified route of administration on 14Mar2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine includes took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiration date: Not reported), via an unspecified route of administration on 20Feb2021 as dose 1, single for covid-19 immunization. It was reported that the injection site was painful, but patient's shoulder muscle hurt for the whole 3 weeks, the big artery y in back of neck hurt for 3 weeks too and it still hurts. For the whole 3 weeks bowel movement was soft. The outcome of the events was unknown.  Follow-up attempts were completed. No further information was expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Migraine with aura, Visual impairment
Clinical narrative: she experienced migraine auras: seeing things that aren't there.; had dizziness; saw black dots; This is a spontaneous report from a contactable consumer. This 68-years old female patient reported for herself that.  A 68-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. Medical history included migraine from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took first dose of BNT162B2 for COVID-19 immunization. Caller is a 68-year-old female who received the second dose of the Pfizer Covid 19 vaccine on 06Feb2021. She states she is doing well. Patient had pneumonia vaccines in the past that she didn't develop antibodies to and had to have additional doses of the vaccine. Is there an antibody test available to see if she have antibodies from the Pfizer Covid 19 vaccine. She had no symptoms after the first dose. The day of the second dose, she experienced migraine auras: seeing things that aren't there. She saw black dots and had dizziness. She never develops a headache. She has been evaluated by her doctor and her eyes are fine. This is not a new thing for her since she experiences migraine auras once or twice a year. Her doctor heard this has been experienced in other patients and thought she should report it. The outcome of event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise
Clinical narrative: feeling tired; headache; feel not well; This is a spontaneous report from a contactable consumer (patient). A 62-years-old female patient received BNT162b2 (Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 14Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 16Mar2021 (Tuesday), patient feel tired, headache, and feeling not well. Patient wanted to know if these were expected side effects and how long would they last. It was unknown if patient received any treatment for the events. The outcome of all the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Facial spasm
Clinical narrative: left side of face started spasming mouth, eye, nose; This is a spontaneous report from a contactable consumer. A 25-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 13Mar2021 14:00 (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced left side of face started spasming mouth, eye, nose (facial spasm) on 13Mar2021. Additional Context: Reporter calling on behalf of fiance. Reporter stated patient has a really rare adverse reaction that happened 40 minutes after COVID 19 vaccine second dose. Patients entire left side of face started spasming, her mouth, eyes, nose, whole left side of face. Reporter stated the reaction is called a hemi facial spasm. Reporter stated patient went to primary care physician, emergency room, a neurologist yesterday as well as going to another neurologist today not sure what is going on. Reporter stated that he is baffled and the reaction was never reported for vaccine. Reporter stated everyone is concerned and he is finding out more information as they go. Reporter goes back and forth to talking to this DSU agent and someone else but then reporter states he is at the (withheld). Reporter stated he has questions about how he is going to be paying hospital bills, neurologist, MRI since they are all expensive. Reporter wanted to know if there was a compensation program for adverse reaction to pay for medical bills since it is going to be really expensive. Reporter stated his main concern is that the patient is 25 and she is healthy, has no medical history or nothing neurological. HCP: Reporter is unsure of patients HCP information. Reporter stated the patient's reaction started around 1430 which was about 40 minutes after receiving COVID 19 vaccine. Caller described the event as hemifacial spasm. Reporter stated the spasm went to the right side for a while, but it is now just on the left side. Reporter stated he feels the reaction has worsened which is why they are going to go see another neurologist. When this DSU agent asked for the NDC, lot number, expiry reporter asked if it was best if he should complete report online if it is required that he provides the information. Reporter decided to continue with the report. Reporter stated that the patient has received COVID tests in the past but all of them have been negative since patient gets tested regularly at work. Reporter stated he was not sure if it was on a military installation, but he knew that the national guard was there but the EMT was giving the vaccine. Clarified that the vaccine was not received on a military base. Reporter declined to complete report at this time since his number just got called at the (withheld). The outcome of the event was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Influenza like illness, Nasopharyngitis, Pain, Pharyngeal swelling
Clinical narrative: itchiness in my throat/very itchy; coughing; coughing maybe even developed a slight fever; A short period of body ache; flu like symptoms; feel like my throat is swelled up and very itchy; keep coughing as if I had a cold; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration in right arm on 26Mar2021 13:00 as dose 1, single for COVID-19 immunization (at the age of 48-year-old). Patient was not pregnant at the time of vaccination. The most recent COVID-19 vaccine was administered at hospital. Medical history included mental impairment and heart rate increased from an unknown date and unknown if ongoing. Patient had allergies to penicillin [benzylpenicillin]. Concomitant medication(s) (within 2 weeks of vaccination) included lisinopril; sertraline; lurasidone hydrochloride (LATUDA) and ascorbic acid, biotin, calcium pantothenate, cyanocobalamin, folic acid, nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride (NEPHROVITE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, the patient had not been tested for COVID-19. The patient experienced itchiness in my throat/very itchy, coughing, coughing maybe even developed a slight fever, a short period of body ache, flu like symptoms, feel like my throat is swelled up and very itchy, keep coughing as if i had a cold on 30Mar2021 04:00. It was reported that, after getting the Pfizer biotech COVID 19 vaccine in a week or so patient started having itchiness in her throat. Started coughing and coughing might be even developed a slight fever. A short period of body ache but went away within a day. The flu like symptoms. Now today she felt like her throat was swelled up and very itchy and continued to keep coughing as if she had a cold. It was unknown if treatment received for the adverse event. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Throat irritation
Clinical narrative: itchiness in my throat/very itchy; coughing; coughing maybe even developed a slight fever; A short period of body ache; flu like symptoms; feel like my throat is swelled up and very itchy; keep coughing as if I had a cold; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration in right arm on 26Mar2021 13:00 as dose 1, single for COVID-19 immunization (at the age of 48-year-old). Patient was not pregnant at the time of vaccination. The most recent COVID-19 vaccine was administered at hospital. Medical history included mental impairment and heart rate increased from an unknown date and unknown if ongoing. Patient had allergies to penicillin [benzylpenicillin]. Concomitant medication(s) (within 2 weeks of vaccination) included lisinopril; sertraline; lurasidone hydrochloride (LATUDA) and ascorbic acid, biotin, calcium pantothenate, cyanocobalamin, folic acid, nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride (NEPHROVITE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and Since the vaccination, the patient had not been tested for COVID-19. The patient experienced itchiness in my throat/very itchy, coughing, coughing maybe even developed a slight fever, a short period of body ache, flu like symptoms, feel like my throat is swelled up and very itchy, keep coughing as if i had a cold on 30Mar2021 04:00. It was reported that, after getting the Pfizer biotech COVID 19 vaccine in a week or so patient started having itchiness in her throat. Started coughing and coughing might be even developed a slight fever. A short period of body ache but went away within a day. The flu like symptoms. Now today she felt like her throat was swelled up and very itchy and continued to keep coughing as if she had a cold. It was unknown if treatment received for the adverse event. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis contact, Dry skin, Rash erythematous
Clinical narrative: red itchy rash on both upper forearms. Spread down both arms to knuckles and it also affected his scalp; contact dermatitis; Scalp was Like scaly; This is a spontaneous report received from a contactable consumer (patient) reported himself. A 67-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: el9267, Expiry Date), dose 1 via an unspecified route of administration, administered in Arm Left on 20Mar2021 10:45 AM (Age at vaccination: 67-years-old) as dose 1, single for COVID-19 immunization. Medical history included blood pressure high, high cholesterol, GERD (gastroesophageal reflux disease) and methyl acrylates allergies. Concomitant medications included propranolol, atorvastatin at 10 mg and lisinopril at 40 mg. The patient previously took carbamates experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, prior to vaccination, the patient was not diagnosed with COVID-19, since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 10:00 AM, patient had red itchy rash on both upper forearms. Spread down both arms to knuckles and it also affected his scalp and his scalp was like scaly and almost like a dandruff type situation over the next few days. Back the story up it basically seemed like a contact dermatitis and he have been on Dupixent (further clarification unknown) which is biological to treat that since the summer time, had been on it for basically from summer time and never had any type of reaction. Treated rash with Clobetasol foam. It took 7 days for rash to clear. All the symptoms lasted through 28Mar2021. The outcome of events was recovered on 28Mar2021.  No follow-up attempts were possible; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus
Clinical narrative: feeling pruritus all over his body/ feeling itching; pain in his arm; right now he feels itching in his shoulders and maybe 10 minutes ago he felt itching in his legs and 15 minutes ago he felt the itching a little in his head.; This is a spontaneous report received from a contactable consumer (patient) reported for himself and from a contactable physician. This report was not related to a study or programme. A 44-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number: unknown, expiry date: unknown), via an unknown route of administration in left arm on 31Mar2021 at 15:30 or 16:00 (at the age of 44-years-old) as dose 1, single for COVID-19 immunisation at Walgreens pharmacy. The patient was picking his son up from school and did not have the lot, expiry date or NDC to provide at this time. The patient's medical history was reported as none. Concomitant medication included clonazepam (CLONAZEPAM) taken orally for an unknown indication from an unknown date. Caller stated due to the pandemic only he has a little bit of anxiety and takes Clonazepam 0.5 mg and takes a half by mouth but has no lot, expiry date or NDC to provide. No history of all previous immunization with the Pfizer vaccine considered as suspect. This was the first. Prior Vaccinations within 4 weeks was reported as none. The patient mentions that he got yesterday the first dose of the Pfizer covid vaccine and nothing happened to him after 30 mins he had to wait after receiving the vaccine. He did not feel any symptoms and everything was fine he thought and he read the paper they gave him and read some of the side effects were like you can feel like difficulty with shortness of breath, swallowing and symptoms with your face and throat and fast heart beat and rashes and weakness; states he did not have anything like that. But today (on 01Apr2021) after he woke up at 5 am he started feeling pruritus all over his body. He claims that he has not other symptom apart from the pain in his arm and he would like to know if this could be caused by the vaccine. After the vaccine, he started feeling itching around 4:00 am-5:00 am and felt the itches all over his body; states he had the vaccine around 3:30pm or 4:00pm and then this morning around 5:00 am was when he started to wake up and started feeling the itching; states he did not feel the itching so bad but he does feel the itching. Stated the itching was the same and for example right now he feels itching in his shoulders and maybe 10 minutes ago he felt itching in his legs and 15 minutes ago he felt the itching a little in his head. The patient did not require treatment, or a visit to the HCP or ER yet. The outcome of the event feeling pruritus all over his body/ feeling itching' was not recovered, while the outcome of the remaining event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Pruritus, Suspected COVID-19, Unevaluable event
Clinical narrative: Got covid toes on two toes on my right feet. Itchy clusters of blisters; Got covid toes on two toes on my right feet. Itchy clusters of blisters; Got COVID toes on two toes on her right feet; Got COVID toes on two toes on her right feet; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 28-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number: Er8732), via an unspecified route of administration, administered in Left Arm on 25Mar2021 17:00 (At the age of 28-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included POTS, migraines, post concussive syndrome from an unknown date and unknown if it ongoing. Concomitant medications included Fludrocortisone, metoprolol, midrodrine, Adderall from an unknown date for an unknown indication (within 2 weeks of vaccination). Patient previously took Hibiclense and experienced allergy. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was diagnosed with COVID. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 31Mar2021 20:00 patient Got COVID toes on two toes on her right feet. Itchy clusters of blisters. Patient did not receive any treatment for the events. The events were non- serious. Outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity, Pyrexia
Clinical narrative: fatigue; body aches; chills; fever; R arm is sore; This is a spontaneous report received from a contactable consumer (patient) reporting for herself. A female patient of an unknown age received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: unknown), via an unknown route of administration on an unknown date as dose 2, single for COVID-19 immunisation. The patient's medical history was reported as none. Concomitant medication was not reported. The patient stated that received second dose of COVID vaccine yesterday, today (on an unknown date) feeling excessive fatigue, body aches, chills and fever and R arm was sore. Event took place after use of product. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Rash, Swelling face
Clinical narrative: developed a rash basically on my face and neck/It was around my face and collar area; I was also short of breath, feeling breathless and my face was swollen.; I was also short of breath, feeling breathless and my face was swollen.; This is a spontaneous report received from a contactable consumer (Patient). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6205), via an unspecified route of administration on 24Feb2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that She received her first dose on 24Feb2021 and about a week later she "developed a rash basically on my face and neck. I thought it might be something that I was using like soap or detergent, but I hadn't changed anything of that. It was around my face and collar area. I did go to the doctor just in case it was shingles and he said that it wasn't. It did resolve on its own and eventually got better. I used Vaseline to rub on the rash and that helped." The caller states that she received her second dose on 17Mar2021, and she reports, "about a week and a half later the same type of rash showed up on my face and neck area. This time it was worse than the first time to the point that my ear lobe was weeping. I was also short of breath, feeling breathless and my face was swollen. When the rash was the worst the breathing was also worse. It does seem to be going away and it's getting better now. she was not really looking for any particular answers, but she felt that it was important to call and report her reaction. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Inflammation
Clinical narrative: pain in my chest; inflammation; This is a spontaneous report from a contactable consumer (patient). A 57-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0151, patient was 57-year-old t the time of vaccination), via an unspecified route of administration, administered in Arm Right on 02Apr2021 at 14:15 as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included systemic lupus. The patient previously took Celebrex and experienced allergy. The patient's concomitant medications were not reported. No other vaccine received in four weeks. It was reported that other vaccine received in two weeks. It was unknown if tested covid post vaccination. On 03Apr2021 at 08:00, the patient experienced pain in my chest, on 03Apr2021, the patient experienced inflammation. It was slight pain to begin with between my heart and lungs. After few days it did not go away. So today I went to Urgent Care. No seriousness criteria were reported. Adverse event result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of pain in my chest, inflammation with injection of Depo-Medrol. The outcomes of events were unknown.   No follow up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Computerised tomogram thorax, Fatigue, Pain in extremity, SARS-CoV-2 antibody test
Clinical narrative: arm got sore the next day; Extreme fatigue; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 56-years-old female patient received BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 11Mar2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization (at the age of 56-years-old). Medical history included type 2 diabetes mellitus and overweight (she's a high risk) and pneumonia (she was hospitalized in Jan2020 with double pneumonia) all from an unknown date and unknown if ongoing. The patient also stated that she qualified to receive the Covid 19 vaccine because she was a high risk due to type 2 diabetes and overweight. She has also had multiple rounds of pneumonia in the past. She actually thought she had the Covid 19 virus in Jan2020. She was hospitalized in Jan2020 with double pneumonia. The emergency room doctor told her that her lungs sounded like a washing machine. The chest x-ray did not show the pneumonia, so she had to have a CT scan of her chest. She was at a New Year's Eve party with about 40 people and all 40 people got sick. She's the only one who had to be hospitalized. All 40 people had various symptoms. She wasn't coughing anything up and she thinks she had more Covid 19 virus symptoms. Hospitals weren't testing for Covid 19 at that time. The Covid 19 antibody test was available in May2020 so she had that done and it showed negative Covid 19 antibodies. She doesn't think those early antibody tests were accurate. Concomitant medication(s) included dulaglutide (TRULICITY) and metformin taken for diabetes mellitus, atorvastatin taken to guard her heart, acetylsalicylic acid (BABY ASPIRIN) and dapagliflozin propanediol monohydrate (FARXIGA) both were taken for an unspecified indication, start and stop date were not reported for all. The patient previously received flu shot at least 6 years ago at a CVS pharmacy in Virginia for flu prophylaxis and stated that the flu vaccine bubbled up under her skin. She called the pharmacist at the and he told her she may have had a subcutaneous injection. She thinks one of the flu vaccines was subcutaneous and one was intramuscular. It was reported that after receiving first dose of vaccine the patient experienced extreme fatigue on 11Mar2021 and had arm got sore the next day on 12Mar2021. The outcome of the events was unknown.   No Follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Abdominal pain, Arthralgia, Chills, Lymphadenopathy, Myalgia
Clinical narrative: horrible chills; extreme abdominal pain with vomiting; extreme abdominal pain with vomiting; muscle aches; sensitive lymph nodes in the neck on the side where vaccine was given; joint pain; This is a spontaneous report from a contactable consumer or other hcp reporting for herself (patient). A 24-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch no/ Lot Number: not reported; expiration date: unknown) via unknown route of administration in left arm on 10Apr2021 10:45 AM (at the age of 24-year-old) as dose 1, single for covid-19 immunization at . Patient's medical history was not reported. Known allergies included Naproxen and cats. Concomitant medications included caffeine, paracetamol [EXCEDRIN TENSION HEADACHE]. Patient wasn't COVID-19 positive prior to vaccination and was not tested for COVID-19 post vaccination No other vaccine was administered within four weeks of vaccination. On 13Apr2021 at 23:00, day 4 of vaccination patient experienced horrible chills, extreme abdominal pain with vomiting, muscle aches and joint pain, sensitive lymph nodes in the neck on the side where vaccine was given. No treatment was given in response to the events. Outcome of all the events was not recovered.  The batch/lot number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Vomiting
Clinical narrative: horrible chills; extreme abdominal pain with vomiting; extreme abdominal pain with vomiting; muscle aches; sensitive lymph nodes in the neck on the side where vaccine was given; joint pain; This is a spontaneous report from a contactable consumer or other hcp reporting for herself (patient). A 24-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch no/ Lot Number: not reported; expiration date: unknown) via unknown route of administration in left arm on 10Apr2021 10:45 AM (at the age of 24-year-old) as dose 1, single for covid-19 immunization at . Patient's medical history was not reported. Known allergies included Naproxen and cats. Concomitant medications included caffeine, paracetamol [EXCEDRIN TENSION HEADACHE]. Patient wasn't COVID-19 positive prior to vaccination and was not tested for COVID-19 post vaccination No other vaccine was administered within four weeks of vaccination. On 13Apr2021 at 23:00, day 4 of vaccination patient experienced horrible chills, extreme abdominal pain with vomiting, muscle aches and joint pain, sensitive lymph nodes in the neck on the side where vaccine was given. No treatment was given in response to the events. Outcome of all the events was not recovered.  The batch/lot number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blepharospasm, Body temperature abnormal, Chills, Diarrhoea
Clinical narrative: low grade temp (99.4); nausea; diarrhea; muscle aches; fatigue; chills; joint pain in both of my hands; sore at the injection side; muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose; muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose; sleeplessness; Eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm/They ran along my left forearm and into my fingers, particularly my left pointer finger; Eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm/They ran along my left forearm and into my fingers, particularly my left pointer finger; This is a spontaneous report from a contactable consumer. A 37-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 11Apr2021 14:00 (Batch/Lot Number: er8729) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included crohn's disease, drug hypersensitivity. The patient experienced that eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm. They ran along my left forearm and into my fingers, particularly my left pointer finger, resulting in that finger moving on its own. By 9 am the next morning, the twitching was still present in my left arm, and I had also developed a low-grade temp (99.4), nausea, diarrhea, muscle aches, fatigue, chills, joint pain in both of my hands, and was sore at the injection side. These symptoms persisted for 48 hours. Additionally, the muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose. I also experienced sleeplessness. By day 4, the symptoms were all lessening, with most gone entirely except the muscle twitching in my left arm and left side of my face. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Facial spasm, Fatigue, Injection site pain, Insomnia, Muscle spasms
Clinical narrative: low grade temp (99.4); nausea; diarrhea; muscle aches; fatigue; chills; joint pain in both of my hands; sore at the injection side; muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose; muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose; sleeplessness; Eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm/They ran along my left forearm and into my fingers, particularly my left pointer finger; Eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm/They ran along my left forearm and into my fingers, particularly my left pointer finger; This is a spontaneous report from a contactable consumer. A 37-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 11Apr2021 14:00 (Batch/Lot Number: er8729) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included crohn's disease, drug hypersensitivity. The patient experienced that eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm. They ran along my left forearm and into my fingers, particularly my left pointer finger, resulting in that finger moving on its own. By 9 am the next morning, the twitching was still present in my left arm, and I had also developed a low-grade temp (99.4), nausea, diarrhea, muscle aches, fatigue, chills, joint pain in both of my hands, and was sore at the injection side. These symptoms persisted for 48 hours. Additionally, the muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose. I also experienced sleeplessness. By day 4, the symptoms were all lessening, with most gone entirely except the muscle twitching in my left arm and left side of my face. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching, Myalgia, Nausea, Pyrexia
Clinical narrative: low grade temp (99.4); nausea; diarrhea; muscle aches; fatigue; chills; joint pain in both of my hands; sore at the injection side; muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose; muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose; sleeplessness; Eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm/They ran along my left forearm and into my fingers, particularly my left pointer finger; Eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm/They ran along my left forearm and into my fingers, particularly my left pointer finger; This is a spontaneous report from a contactable consumer. A 37-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 11Apr2021 14:00 (Batch/Lot Number: er8729) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included crohn's disease, drug hypersensitivity. The patient experienced that eight hours after I received my shot in my left arm, I began experiencing muscle twitching/spasm in that arm. They ran along my left forearm and into my fingers, particularly my left pointer finger, resulting in that finger moving on its own. By 9 am the next morning, the twitching was still present in my left arm, and I had also developed a low-grade temp (99.4), nausea, diarrhea, muscle aches, fatigue, chills, joint pain in both of my hands, and was sore at the injection side. These symptoms persisted for 48 hours. Additionally, the muscle spasms continued and spread to the left side of my face, resulting in twitching in my left cheek, left eyelid, and left side of my nose. I also experienced sleeplessness. By day 4, the symptoms were all lessening, with most gone entirely except the muscle twitching in my left arm and left side of my face. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Losing her hair; This is a spontaneous report from a contactable consumer or other non healthcare professional (reporter's friend). A 85-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: not reported), via an unspecified route of administration as (at age of 85-years-old) dose number unknown, single for covid-19 immunisation. Medical history included diabetic, high blood pressure (Takes high blood pressure medication (name not specified). Past drug included statins (name not specified). On an unspecified date, the patient experienced losing her hair. The reporter has heard that she needs to wait 2 weeks after her second Pfizer vaccine to travel. She wanted to find out if that is correct information and stated that she had her second vaccine on 15Apr2021 and had no issues at all. She states her friend, reports losing her hair after receiving the Pfizer Covid vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.